EXPD vs. WST
Compare and contrast key facts about Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST).
Performance
EXPD vs. WST - Performance Comparison
Loading graphics...
EXPD vs. WST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EXPD Expeditors International of Washington, Inc. | -3.88% | 36.16% | -11.86% | 23.86% | -21.68% | 42.50% | 23.47% | 16.17% | 6.52% | 23.93% |
WST West Pharmaceutical Services, Inc. | -8.82% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
Fundamentals
EXPD:
$19.28B
WST:
$18.22B
EXPD:
$5.94
WST:
$6.79
EXPD:
24.10
WST:
36.93
EXPD:
1.76
WST:
5.93
EXPD:
8.19
WST:
5.74
EXPD:
$11.07B
WST:
$3.07B
EXPD:
$1.23B
WST:
$1.10B
EXPD:
$1.14B
WST:
$723.60M
Returns By Period
In the year-to-date period, EXPD achieves a -3.88% return, which is significantly higher than WST's -8.82% return. Over the past 10 years, EXPD has underperformed WST with an annualized return of 12.77%, while WST has yielded a comparatively higher 13.95% annualized return.
EXPD
- 1D
- 1.24%
- 1M
- -1.24%
- YTD
- -3.88%
- 6M
- 17.45%
- 1Y
- 20.56%
- 3Y*
- 10.48%
- 5Y*
- 6.88%
- 10Y*
- 12.77%
WST
- 1D
- 2.24%
- 1M
- -1.45%
- YTD
- -8.82%
- 6M
- -4.29%
- 1Y
- 12.35%
- 3Y*
- -9.99%
- 5Y*
- -2.27%
- 10Y*
- 13.95%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXPD vs. WST — Risk / Return Rank
EXPD
WST
EXPD vs. WST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EXPD | WST | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.63 | 0.30 | +0.33 |
Sortino ratioReturn per unit of downside risk | 1.02 | 0.83 | +0.18 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.10 | +0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.33 | 0.53 | +0.79 |
Martin ratioReturn relative to average drawdown | 3.13 | 1.10 | +2.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EXPD | WST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.63 | 0.30 | +0.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.26 | -0.06 | +0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.41 | +0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.47 | 0.37 | +0.10 |
Correlation
The correlation between EXPD and WST is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
EXPD vs. WST - Dividend Comparison
EXPD's dividend yield for the trailing twelve months is around 1.08%, more than WST's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXPD Expeditors International of Washington, Inc. | 1.08% | 1.03% | 1.32% | 1.08% | 1.29% | 0.86% | 1.09% | 1.28% | 1.32% | 1.30% | 1.51% | 1.60% |
WST West Pharmaceutical Services, Inc. | 0.34% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
Drawdowns
EXPD vs. WST - Drawdown Comparison
The maximum EXPD drawdown since its inception was -58.07%, roughly equal to the maximum WST drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for EXPD and WST.
Loading graphics...
Drawdown Indicators
| EXPD | WST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.07% | -59.29% | +1.22% |
Max Drawdown (1Y)Largest decline over 1 year | -15.88% | -24.70% | +8.82% |
Max Drawdown (5Y)Largest decline over 5 years | -35.62% | -59.29% | +23.67% |
Max Drawdown (10Y)Largest decline over 10 years | -35.62% | -59.29% | +23.67% |
Current DrawdownCurrent decline from peak | -13.21% | -46.22% | +33.01% |
Average DrawdownAverage peak-to-trough decline | -13.66% | -16.79% | +3.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.74% | 12.05% | -5.31% |
Volatility
EXPD vs. WST - Volatility Comparison
The current volatility for Expeditors International of Washington, Inc. (EXPD) is 6.36%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 9.11%. This indicates that EXPD experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EXPD | WST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.36% | 9.11% | -2.75% |
Volatility (6M)Calculated over the trailing 6-month period | 25.17% | 24.91% | +0.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.80% | 41.43% | -8.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.40% | 40.04% | -13.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.89% | 34.28% | -9.39% |
Financials
EXPD vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Expeditors International of Washington, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXPD vs. WST - Profitability Comparison
EXPD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Expeditors International of Washington, Inc. reported a gross profit of 0.00 and revenue of 2.86B. Therefore, the gross margin over that period was 0.0%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.
EXPD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Expeditors International of Washington, Inc. reported an operating income of 250.91M and revenue of 2.86B, resulting in an operating margin of 8.8%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.
EXPD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Expeditors International of Washington, Inc. reported a net income of 200.71M and revenue of 2.86B, resulting in a net margin of 7.0%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.